jennifer voyksner
scientific co-founder and chief strategy officer at immunogenx
biotechnology, operations
raleigh, north carolina, united states
Gather verified email addresses & phone numbers directly from LinkedIn
202M+
Contacts
44M+
Companies
57M+
Emails
9M+
Phone numbers
chief executive officer
Professional Email
jsy****@syagen.com
Personal Email
****@****.com
Work Phone
(714) 357*****
Mobile
(714) 357*****
Local Location
newport beach, california, united states
HQ Location
Newport Beach, california, united states
Industry
biotechnology,
Designation
chief executive officer
Birthday
-
Gender
male
HQ Location
Newport Beach, california, united states
Industry
pharmaceuticals
Employees
6
Founded
2013

Install the Orion chrome extension from the Web Store. Sign up using your email address.

The Extension will sync with your LinkedIn from where you can discover in-depth Prospects' profiles, company information and Find Similar details.

Get detailed insights of Prospects Company Profile, Email ID, Phone Number, Location or Similar Designation and much more.
1
Number of Companies Worked For
jack syage is currently employed at Immunogenx. jack is an experienced professional working at ImmunogenX as the chief executive officer. jacks phone number is (714) 357***** and email is jsy****@syagen.com to get more information install Orion extension.
jack syage is currently employed at Immunogenx.
At present, jack syage is serving as the chief executive officer.
The professional email used by jack syage is jsy****@syagen.com.
jack syage's professional contact number is (714) 357*****.
Jennifer Voyksner are some of the colleagues working with jack syage.
Daryle Smith, Gary Schoettmer, Chris Anthony, Ed Cantera, Daniel Ho are some of the other counterparts holding the similar designation in other organizations like jack syage.
jack syage has worked for immunogenxfalse so far.
According to the Immunogenx Summary, Immungenx inc. is a clinical company that was founded in 2013 and supported by a team of world renowned scientists and collaborators to address critical needs for individuals with suspected or diagnosed celiac disease. Immungenx is currently conducting two Phase 2b clinical trials and has completed a study on latiglutenase, an investigational medication that is designed to relieve common symptoms of celiac disease..
The company is headquartered at Newport Beach, California, United states.
jack syage is chief executive officer at Immunogenx.
jack syage is currently residing in newport beach, california, united states.
jack syage is currently working with the biotechnology, industry.
Nearly 6 is the total headcount of the company.
scientific co-founder and chief strategy officer at immunogenx
biotechnology, operations
raleigh, north carolina, united states